Patent · US Active

Method of enriching a target nucleic acid at a TNFRSF1B gene locus in a sample from a subject with inflammatory bowel disease

US11180565B2 · kind B2 · utility

3Cited by

2References

15Claims

0Family size

Assignee

Cedars Sinai Medical Center · US

Inventors

Dermot P. McGovern · Los Angeles, US
Stephan R. Targan · Santa Monica, US
Dalin Li · Walnut, US

Key dates

Filing date	Mar 10, 2020
Grant date	Nov 23, 2021
Priority date	—
Expiry date	Mar 10, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/56
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The aspects disclosed herein describe methods of identifying a subject that is non-responsive to anti-TNF therapy. The aspects disclosed herein further provide for a method of selecting a therapy for a subject with Inflammatory Bowel Disease (IBD), and treating the subject with the therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.